Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsNeera Dahl, MD, PhD
Professor AdjunctAbout
Copy Link
Titles
Professor Adjunct
Director, Nephrology Clinical Trials Program, Nephrology
Positions outside Yale
Medical Director, Outpatient Dialysis, Nephrology, DaVita New Haven
Biography
Dr. Dahl has expertise in diagnosis and management of inherited (or genetically based) kidney disease. Her main focus has been ADPKD and other cystic kidney diseases which mimic ADPKD. She is the medical director of the New Haven DaVita unit providing in center hemodialysis, home hemodialysis and peritoneal dialysis. She is the Director of the Nephrology Clinical Trials program overseeing studies in ADPKD, diabetes and hypertension. In collaboration with Dr. Dinesh Singh she runs the Yale Kidney Stone Clinic.
Appointments
Nephrology
Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Beth Israel Deaconess Medical Center (2002)
- Resident
- Beth Israel Deaconess Medical Center (1999)
- Intern
- BIDMC, Harvard Medical School (1997)
- PhD
- Tufts University (1996)
- MD
- Tufts University School of Medicine (1996)
- BA
- Johns Hopkins University (1987)
- Postdoctoral, PhD
- Tufts University School of Medicine and Sackler School of Biomedical Science
Research
Copy Link
Overview
In collaboration with Dr. Tinika Montgomery (nephrology), Drs. Dinesh Singh, Piruz Motamedinia, and Tim Tran (urology) we have created a Kidney Stone Registry to track important aspects of kidney stone management.
In the inherited kidney disease space I am most interested in those aspects of clinical research which improve care for ADPKD patients.
Medical Research Interests
ORCID
0000-0001-5809-9961
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Stefan Somlo, MD
Whitney Besse, MD
Cassius Iyad Ochoa Chaar, MD, MPH, MS, RPVI
Gilbert Moeckel, MD, PhD, FASN
Abinet Aklilu, MD, MPH
Margaret Bia, MD
Kidney Diseases
Nephrology
Publications
2025
Resolution of acute kidney injury following intensive dialysis for oxalate nephropathy.
Roth J, Buglioni A, Dahl N. Resolution of acute kidney injury following intensive dialysis for oxalate nephropathy. Clinical Nephrology 2025, 104: 440-445. PMID: 40454527, DOI: 10.5414/cn111664.Peer-Reviewed Original ResearchConceptsAcute kidney injuryOxalate nephropathyKidney injuryStage III acute kidney injuryIII acute kidney injuryResolution of acute kidney injuryUrinary excretion of oxalateIncreased urinary excretion of oxalateAbsorption of dietary oxalateDeposition of calcium oxalate crystalsIncreased absorption of dietary oxalateSerum oxalate levelsExcretion of oxalateIncreased urinary excretionChronic kidney diseaseRenal outcomesRenal recoveryEnteric hyperoxaluriaBariatric proceduresFat malabsorptionIntensive dialysisSecondary hyperoxaluriaRenal parenchymaBiliopancreatic diversionBariatric patientsKidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review
Borghol A, Azooz M, Bou Antoun M, Souvalian L, Shami B, Mina J, Munairdjy Debeh F, Ghanem A, Sandouk H, Rangarajan V, Hanna D, Naranjo C, Drexler Y, Norouzi S, Noruzi A, Salih M, Klett D, Porter I, Dahl N, Chebib F. Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. Renal Failure 2025, 47: 2570071. PMID: 41208250, PMCID: PMC12604128, DOI: 10.1080/0886022x.2025.2570071.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsAutosomal dominant polycystic kidney diseaseVasopressin V2 receptor antagonistNon-Contrast Computed TomographyCorrection of metabolic derangementsImpaired urinary drainageV2 receptor antagonistLow urine pHTreatment of stone diseaseStone-free rateDominant polycystic kidney diseaseDiagnostic gold standardCumulative radiation exposureLow-dose CTPolycystic kidney diseaseCalcium oxalate stonesLonger operative timeReceptor antagonistUrological interventionUrinary drainageUrine volumeAggressive hydrationDiagnostic challengeClinical manifestationsMetabolic abnormalitiesStone riskGenetic Testing in the Management of Adult CKD
Chebib F, Wang X, Udani S, Westemeyer M, Clark D, Zhang Z, Bloom M, Milo Rasouly H, Kolupaeva V, Mizani M, Dossabhoy N, Faravardeh A, Demko Z, Kotte S, Punj S, Chapman S, Rabinowitz M, Schneider R, Tabriziani H, Bhorade S, Gharavi A, Dahl N. Genetic Testing in the Management of Adult CKD. Journal Of The American Society Of Nephrology 2025 DOI: 10.1681/asn.0000000913.Peer-Reviewed Original ResearchCitationsAltmetricConceptsGenetic testingPositive test findingsImpact of genetic testingAdoption of genetic testingHealth care systemManagement of CKDClinical utilityPublic health burdenTest findingsClinical managementPositive genetic findingsCare systemDiabetes-related nephropathyPhysician estimatesPrognosis of patientsHealth burdenCKD diagnosisSuboptimal managementSingle-armStudy patientsMulticenter studyCKD patientsClinical historyClinical cohortQuestionnaireRefining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease.
Dahl N, Torres V. Refining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease. Kidney360 2025 PMID: 41148212, DOI: 10.34067/kid.0000001039.Peer-Reviewed Original ResearchAltmetricAutosomal Recessive PKD: Not Just for Kids, Long-Term Outcomes in Early vs. Late-Onset Disease
Borghol A, Potretzke T, Gregory A, Yang H, Smith B, Elbarougy D, Thompson W, Dahl N, Torres V, Gitomer B, Ong A, Chebib F, Harris P, Hanna C. Autosomal Recessive PKD: Not Just for Kids, Long-Term Outcomes in Early vs. Late-Onset Disease. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.2025bf6aaxjq. DOI: 10.1681/asn.2025bf6aaxjq.Peer-Reviewed Original ResearchKidney and Liver Cysts in Patients with Neuroendocrine Tumors
Jameel R, Elbarougy D, Yang H, Cruz C, Harris P, Dahl N. Kidney and Liver Cysts in Patients with Neuroendocrine Tumors. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.202597hwfp8k. DOI: 10.1681/asn.202597hwfp8k.Peer-Reviewed Original ResearchKidney Outcomes in Patients with ADPKD with or Without a Family History
Jameel R, Elbarougy D, Yang H, Cruz C, Gregory A, Dahl N, Torres V, Harris P. Kidney Outcomes in Patients with ADPKD with or Without a Family History. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.2025zj1pe2fj. DOI: 10.1681/asn.2025zj1pe2fj.Peer-Reviewed Original ResearchGenetic and Clinical Profiles of ADPKD in Two Population-Based Cohorts
Elbarougy D, Yang H, McDonnell S, Frank J, Ma J, Gregory A, Cruz C, Dahl N, Torres V, Larson N, Harris P. Genetic and Clinical Profiles of ADPKD in Two Population-Based Cohorts. Journal Of The American Society Of Nephrology 2025, 36: 10.1681/asn.2025m50bz5vn. DOI: 10.1681/asn.2025m50bz5vn.Peer-Reviewed Original ResearchDeep Learning-Based Instance-Level Segmentation of Kidney and Liver Cysts in CT Images of Patients Affected by Polycystic Kidney Disease.
Gregory A, Khalifa M, Im J, Ramanathan S, Elbarougy D, Cruz C, Yang H, Denic A, Rule A, Chebib F, Dahl N, Hogan M, Harris P, Torres V, Erickson B, Potretzke T, Kline T. Deep Learning-Based Instance-Level Segmentation of Kidney and Liver Cysts in CT Images of Patients Affected by Polycystic Kidney Disease. Kidney360 2025 PMID: 40811034, DOI: 10.34067/kid.0000000924.Peer-Reviewed Original ResearchCitationsConceptsAutosomal dominant polycystic kidney diseaseLiver cystsCT scanPolycystic kidney diseaseAbdominal CTCT imagesAdvanced biomarkersKidney diseaseCT scans of patientsTotal cyst numberContrast-enhanced CTCT images of patientsNon-contrast CTDominant polycystic kidney diseasePrediction of disease progressionScans of patientsImages of patientsADPKD patientsInter-readerLiver volumeTotal kidneyDisease progressionImage-based biomarkersPatientsImaging modalitiesAutosomal dominant polycystic kidney disease without apparent family history: A single-center experience.
Samuels M, Maarouf O, Zeng W, Hamrahian M, Dahl N, Zhang J. Autosomal dominant polycystic kidney disease without apparent family history: A single-center experience. Clinical Nephrology 2025, 104: 144-151. PMID: 40329829, DOI: 10.5414/cn111677.Peer-Reviewed Original ResearchConceptsAutosomal dominant polycystic kidney diseaseDisease-causing variantsDominant polycystic kidney diseaseFamily historyPolycystic kidney diseaseAutosomal dominant polycystic kidney disease phenotypeKidney diseaseHistory of autosomal dominant polycystic kidney diseaseFamily history of autosomal dominant polycystic kidney diseaseSingle-center experienceApparent family historyThomas Jefferson University HospitalGenetic test resultsADPKD patientsPKD patientsKidney functionGenetic diagnosisGenetic testingUniversity HospitalAccurate diagnosisPatientsKidney failureClinical diagnosisDisease accountPracticing nephrologists
Academic Achievements & Community Involvement
Copy Link
Activities
activity Scientific Advisory Board
10/01/2018 - PresentAdvisory BoardsAdvisorDetailsPKD Foundationinvolved in grant review and patient outreach projects with the PKD Foundationactivity Medical Review Board
10/01/2015 - PresentAdvisory BoardsBoard MemberDetailsESRD Network of New EnglandHelped determine focus of the ESRD Network projectsactivity National Kidney Foundation, CT Chapter
10/01/2008 - PresentAdvisory BoardsBoard MemberDetailsNational Kidney Foundationactivity American Journal of Kidney Disease
2007 - PresentJournal ServiceRevieweractivity Clinical Journal of the American Society of Nephrology
2007 - PresentJournal ServiceReviewer
Honors
honor ISN Travel Grant
01/01/2013National AwardWorld Congress of NephrologyDetailsUnited Stateshonor Sugarman Postdoctoral Training Grant
01/01/2002, 01/01/2001National AwardNational Kidney FoundationDetailsUnited Stateshonor Training Grant (Renal Fellow)
01/01/2001, 01/01/2000Other AwardHarvard Medical SchoolDetailsUnited Stateshonor Medical Scientist Training Program
01/01/1996, 01/01/1987Regional AwardTufts UniversityDetailsUnited Stateshonor Alpha Omega Alpha
01/01/1996Other AwardTufts University School of MedicineDetailsUnited States
News
Copy Link
News
- February 15, 2024
Hybrid Approach to Arteriovenous Fistula Aneurysm Repair
- July 13, 2023
Support System, Consistency Important For Dialysis Patients During Pandemic (Discoveries & Impact July 2023)
- December 19, 2022
Yale Named Center of Excellence by Polycystic Kidney Disease (PKD) Foundation
- November 12, 2022Source: Web MD
Talking to Your Kids About ADPKD
Get In Touch
Copy Link